【YUNG SHIN】Announcement by Important Subsidiary Yung Shin Pharmaceutical Industrial Co., Ltd. Regarding Important Board Resolutions
Yung Shin Pharmaceutical Industrial Co., Ltd., an important subsidiary of Yung Shin, announced board resolutions approving the 2025 business report, financial statements, profit distribution, and remuneration and performance bonuses for the Chairman and General Manager for the year 2025.
📋 Article Processing Timeline
- 📰 Published: May 5, 2026 at 09:00
- 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 6, 2026 at 08:54 (54 min after Collected)
1. Date of occurrence of the event: 2026/05/05
2. Company name: Yung Shin Pharmaceutical Industrial Co., Ltd.
3. Relationship with the company (please enter "this company" or "subsidiary"): Subsidiary
4. Mutual shareholding ratio: Not applicable
5. Reason for occurrence: Announcement on behalf of an important subsidiary regarding important resolutions passed by the board of directors.
(1) Approval of the 2025 business report and financial statements.
(2) Approval of the 2025 profit distribution.
(3) Approval of the 2025 employee remuneration for the Chairman and General Manager.
(4) Approval of the 2025 performance bonuses for the Chairman and General Manager.
6. Countermeasures: None
7. Other matters that need to be specified (if the subject of the event or resolution is a public offering company or above, this material information also complies with Article 7, Paragraph 9 of the Enforcement Rules of the Securities Exchange Act, which specifies matters that have a material impact on shareholders' equity or securities prices):
In accordance with Article 128-1 of the Company Act, for a company limited by shares organized by a single corporate shareholder, the functions of the shareholders' meeting shall be exercised by the board of directors.
2. Company name: Yung Shin Pharmaceutical Industrial Co., Ltd.
3. Relationship with the company (please enter "this company" or "subsidiary"): Subsidiary
4. Mutual shareholding ratio: Not applicable
5. Reason for occurrence: Announcement on behalf of an important subsidiary regarding important resolutions passed by the board of directors.
(1) Approval of the 2025 business report and financial statements.
(2) Approval of the 2025 profit distribution.
(3) Approval of the 2025 employee remuneration for the Chairman and General Manager.
(4) Approval of the 2025 performance bonuses for the Chairman and General Manager.
6. Countermeasures: None
7. Other matters that need to be specified (if the subject of the event or resolution is a public offering company or above, this material information also complies with Article 7, Paragraph 9 of the Enforcement Rules of the Securities Exchange Act, which specifies matters that have a material impact on shareholders' equity or securities prices):
In accordance with Article 128-1 of the Company Act, for a company limited by shares organized by a single corporate shareholder, the functions of the shareholders' meeting shall be exercised by the board of directors.